Evaluation of Cervical Myelopathy Using Apparent Diffusion Coefficient Measured by Diffusion-Weighted Imaging

References

1. 1.↵
   1. Takahashi M,
   2. Yamashita Y,
   3. Sakamoto Y,
   4. et al.

   Chronic cervical cord compression: clinical significance of increased signal intensity on MR imaging. Radiology 1989;173:219–24

   PubMedWeb of Science
2. 2.↵
   1. Bucciero A,
   2. Vizioli L,
   3. Carangelo B,
   4. et al.

   MR signal enhancement in cervical spondylotic myelopathy: correlation with surgical results in 35 cases. J Neurosurg Sci 1993;37:217–22

   PubMed
3. 3.↵
   1. Chen J,
   2. Lyu K,
   3. Lee T,
   4. et al.

   Intramedullary high signal intensity on T2-weighted MR images in cervical spondylotic myelopathy: prediction of prognosis with type of intensity. Radiology 2001;221:789–94

   PubMedWeb of Science
4. 4.↵
   1. Fernández de Rota JJ,
   2. Meschian S,
   3. Fernández de Rota A,
   4. et al.

   Cervical spondylotic myelopathy due to chronic compression: the role of signal intensity changes in magnetic resonance images. J Neurosurg Spine 2007;6:17–22

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Haupts M,
   2. Hann J

   . Further aspects of MR-signal enhancements in correlation to clinical and cerebrospinal fluid (CSF) findings. Neuroradiology 1988;30:545–46

   CrossRefPubMed
6. 6.↵
   1. Mamata H,
   2. Jolesz F,
   3. Maier S

   . Apparent diffusion coefficient and fractional anisotropy in spinal cord: age and cervical spondylosis-related changes. J Magn Reson Imaging 2005;22:38–43

   CrossRefPubMed
7. 7.↵
   1. Matsumoto M,
   2. Toyama Y,
   3. Ishikawa M,
   4. et al.

   Increased signal intensity of the spinal cord on magnetic resonance images in cervical compressive myelopathy: does it predict the outcome of conservative treatment? Spine (Phila Pa 1976) 2000;25:677–82

   CrossRef
8. 8.↵
   1. Schaefer PW,
   2. Grant PE,
   3. Gonzales RG

   . Diffusion-weighted MR imaging of the brain. Radiology 2000;217:331–45

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Fischbein NJ,
   2. Dillon WP,
   3. Cobbs C,
   4. et al.

   The “presyrinx” state: is there a reversible myelopathic condition that may precede syringomyelia? Neurosurg Focus 2000;8:E4

   PubMed
10. 10.↵
    1. Suri A,
    2. Chabbra R,
    3. Mehta V,
    4. et al.

    Effect of intramedullary signal changes on the surgical outcome of patients with cervical spondylotic myelopathy. Spine J 2003;3:33–45

    CrossRefPubMed
11. 11.↵
    1. Matsuda Y,
    2. Miyazaki K,
    3. Tada K,
    4. et al.

    Increased MR signal intensity due to cervical myelopathy: analysis of 29 surgical cases. J Neurosurg 1991;74:887–92

    PubMedWeb of Science
12. 12.↵
    1. Ries M,
    2. Jones R,
    3. Dousset V,
    4. et al.

    Diffusion tensor MRI of the spinal cord. Magn Reson Med 2000;44:884–92

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Castillo M,
    2. Arbelaez A,
    3. Fisher LL,
    4. et al.

    Diffusion-weighted imaging in patients with cervical spondylosis. Int J Neuroradiol 1999;5:79–85
14. 14.↵
    1. Aota Y,
    2. Niwa T,
    3. Uesugi M,
    4. et al.

    The correlation of diffusion-weighted magnetic resonance imaging in cervical compression myelopathy with neurologic and radiologic severity. Spine 2008;33:814–20

    CrossRefPubMed
15. 15.↵
    1. Hirabayashi K

    . Expansive open-door laminoplasty for cervical spondylotic myelopathy. Jpn J Surg 1978;32:1159–63
16. 16.↵
    1. Demir A,
    2. Ries M,
    3. Moonen C,
    4. et al.

    Diffusion-weighted MR imaging with apparent diffusion coefficient and apparent diffusion tensor maps in cervical spondylotic myelopathy. Radiology 2003;229:37–43

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Hori M,
    2. Okubo T,
    3. Aoki S,
    4. et al.

    Line scan diffusion tensor MRI at low magnetic field strength: feasibility study of cervical spondylotic myelopathy in an early clinical stage. J Magn Reson Imaging 2006;23:183–88

    CrossRefPubMed